SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Antagonism between Gdf6a and retinoic acid pathways controls timing of retinal neurogenesis and growth of the eye in zebrafish.

Valdivia, LE; Lamb, DB; Horner, W; Wierzbicki, C; Tafessu, A; Williams, AM; Gestri, G; Krasnow, AM; Vleeshouwer-Neumann, TS; Givens, M; et al. Valdivia, LE; Lamb, DB; Horner, W; Wierzbicki, C; Tafessu, A; Williams, AM; Gestri, G; Krasnow, AM; Vleeshouwer-Neumann, TS; Givens, M; Young, RM; Lawrence, LM; Stickney, HL; Hawkins, TA; Schwarz, QP; Cavodeassi, F; Wilson, SW; Cerveny, KL (2016) Antagonism between Gdf6a and retinoic acid pathways controls timing of retinal neurogenesis and growth of the eye in zebrafish. Development, 143 (7). pp. 1087-1098. ISSN 1477-9129 https://doi.org/10.1242/dev.130922
SGUL Authors: Cavodeassi, Florencia

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

Maintaining neurogenesis in growing tissues requires a tight balance between progenitor cell proliferation and differentiation. In the zebrafish retina, neuronal differentiation proceeds in two stages with embryonic retinal progenitor cells (RPCs) of the central retina accounting for the first rounds of differentiation, and stem cells from the ciliary marginal zone (CMZ) being responsible for late neurogenesis and growth of the eye. In this study, we analyse two mutants with small eyes that display defects during both early and late phases of retinal neurogenesis. These mutants carry lesions in gdf6a, a gene encoding a BMP family member previously implicated in dorsoventral patterning of the eye. We show that gdf6a mutant eyes exhibit expanded retinoic acid (RA) signalling and demonstrate that exogenous activation of this pathway in wild-type eyes inhibits retinal growth, generating small eyes with a reduced CMZ and fewer proliferating progenitors, similar to gdf6a mutants. We provide evidence that RA regulates the timing of RPC differentiation by promoting cell cycle exit. Furthermore, reducing RA signalling in gdf6a mutants re-establishes appropriate timing of embryonic retinal neurogenesis and restores putative stem and progenitor cell populations in the CMZ. Together, our results support a model in which dorsally expressed gdf6a limits RA pathway activity to control the transition from proliferation to differentiation in the growing eye.

Item Type: Article
Additional Information: © 2016. Published by The Company of Biologists Ltd This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Keywords: BMP, Ciliary marginal zone, Gdf6a, Neurogenesis, Retinal stem cells, Retinoic acid, Zebrafish, Animals, Bone Morphogenetic Proteins, Cell Cycle, Cell Proliferation, Embryo, Nonmammalian, Growth Differentiation Factor 6, Neurogenesis, Retina, Signal Transduction, Stem Cells, Tretinoin, Zebrafish, Zebrafish Proteins, 06 Biological Sciences, 11 Medical And Health Sciences
SGUL Research Institute / Research Centre: Academic Structure > Institute of Medical & Biomedical Education (IMBE)
Academic Structure > Institute of Medical & Biomedical Education (IMBE) > Centre for Biomedical Education (INMEBE)
Journal or Publication Title: Development
ISSN: 1477-9129
Language: eng
Dates:
DateEvent
5 April 2016Published
18 February 2016Published Online
8 February 2016Accepted
Publisher License: Creative Commons: Attribution 3.0
Projects:
Project IDFunderFunder ID
MR/L003775/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
BB/H012516/1Biotechnology and Biological Sciences Research Councilhttp://dx.doi.org/10.13039/501100000268
088175Wellcome Trusthttp://dx.doi.org/10.13039/100004440
C11766/A11631Cancer Research UKhttp://dx.doi.org/10.13039/501100000289
089227Wellcome Trusthttp://dx.doi.org/10.13039/100004440
104682Wellcome Trusthttp://dx.doi.org/10.13039/100004440
R15 EY023745-01NEI NIH HHSUNSPECIFIED
R15 EY023745NEI NIH HHSUNSPECIFIED
G0900994Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
PubMed ID: 26893342
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/109998
Publisher's version: https://doi.org/10.1242/dev.130922

Actions (login required)

Edit Item Edit Item